XYTOS Introduces Their Next Generation Cancer Treatment and Diagnostic Procedure

XYTOS, Inc. (the "Company") (NASDAQ:XYTS) working at the forefront of the future of the science of medicine and committed to becoming a global leader in the introduction of next generation Bio-MedicalTechnologies in the areas of Stem Cell Therapy, Tissue Engineering and Cellular Medicine is pleased to introduce our Next Generation Cancer Treatment and Diagnostic Procedure; the first of several bio-medicaltechnology introductions that XYTOS has planned.

Imagine a future where a diagnosis of cancer is considered an inconvenience and not a life threatening disease. Imagine a future where cancer diagnostics and treatment are completely non-invasive and non-toxic. Imagine a future where cancer is detected as single cells, years before it becomes a detectable tumor. Imagine a future where the fear of testing for cancer is eliminated by the use of a completely non-invasive procedure. Imagine the possibility of transforming cancer from the # 1 killer of Americans under the age of 85, to a disease of the past. XYTOS is making these possibilities a reality.

Tim Cook, Chairman and CEO of XYTOS, Inc., commented, "As I stated in an earlier news release, we have worked for many years positioning this company to become a global leader on the forefront of the next generation of medicine. We have quietly worked on our research and development for the past several years and we are now ready to introduce to the world Next Generation Bio-MedicalTechnolog ies. We are obviously very exited about the results that we have achieved with our Cancer Treatment and Diagnostic Procedure, and our treatment and diagnostic procedure will change the way cancer is perceived. We look forward to sharing the information with all interested readers, but because the details of the treatment are too extensive to disseminate in a news release we invite our investors as well as all interested parties to review the information on our website www.xytos.com to clearly see the results that we achieved over the past years."

About XYTOS, Inc.

XYTOS working at the forefront of the "Science of Medicine" is a Bio-Medical Technologies Company concentrating on the research, development and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering and Cellular Medicine.

Related Articles

• Ormat Technologies to Supply a Series of Recovered Energy Generation Units to ICQ Eenergeticoa in Italy
  18 November 2005



• KEE Technologies Releases the ZYNX X20 Multi Functional Console - The Next Generation of Complete Precision Agriculture Systems
  30 October 2005



• Analytical Spectral Devices, Inc., Introduces FieldSpec® 3, the Next Generation of Field Spectroradiometers
  26 October 2005



• Webcom, Inc. Selected by Cray, Inc. to Automate the Quotation and Proposal Generation Process
  13 October 2005



• Alphalogix Spins Off Its Next Generation of Integrated Conferencing Products as BrightCom
  5 October 2005



• Four Disruptive Technologies for the Next Decade Investment Report Just Released
  13 September 2005



• The Next Generation Internet: IPv6 and the Turning Tide in Global Communications
  8 September 2005



• VBox Communications Unveils the USB-S 2230, a New Generation of Satellite DVB-S Receivers
  23 August 2005



• Sales Lead Generation Expert Adds New Clients
  14 August 2005



• BancTec Launches Next Generation Remittance Processing Solution
  25 July 2005